Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
US Army
Argus Health
Accenture
AstraZeneca
Baxter
Harvard Business School
Chinese Patent Office
Merck

Generated: December 10, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LEVOCETIRIZINE DIHYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Levocetirizine Dihydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00150761 Facial Thermography Study of Levocetirizine Versus Cetirizine Completed UCB Pharma Phase 4 Phase IV, human pharmacology, exploratory, randomized, 3-way (3 treatment periods) cross-over, double blind, double dummy, placebo controlled study to compare levocetirizine and cetirizine by means of IR thermography.
NCT00152412 Open Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering From Allergic Rhinitis Completed UCB Pharma Phase 2 4 week open study to evaluate the safety of levocetirizine in young children (2 - 6 years) suffering from allergic rhinitis. As secondary objective, this study will assess the efficacy of the treatment by means of the T4SS (Total 4 symptoms scores of allergic rhinitis) and each of the 4 individual rhinitis symptom scores
NCT00152464 Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM) Completed UCB Pharma Phase 3 The Early Prevention of Asthma in Atopic Children (EPAAC™) . 24 months study to evaluate the efficacy and safety of levocetirizine (LCTZ) in preventing the onset of asthma in 12 to 24 months old children.
NCT00160537 POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis) Completed UCB Pharma Phase 4 Comparative study on clinical efficacy and safety of levocetirizine and desloratadine as measured by the subject's satisfaction/dissatisfaction after one week of treatment
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Levocetirizine Dihydrochloride

Condition Name

Condition Name for Levocetirizine Dihydrochloride
Intervention Trials
Allergic Rhinitis 12
Rhinitis, Allergic, Seasonal 6
Rhinitis 6
Perennial Allergic Rhinitis 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Levocetirizine Dihydrochloride
Intervention Trials
Rhinitis 36
Rhinitis, Allergic 32
Rhinitis, Allergic, Perennial 10
Rhinitis, Allergic, Seasonal 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Levocetirizine Dihydrochloride

Trials by Country

Trials by Country for Levocetirizine Dihydrochloride
Location Trials
United States 69
Spain 7
Germany 6
Korea, Republic of 5
France 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Levocetirizine Dihydrochloride
Location Trials
Georgia 4
California 4
Tennessee 4
Texas 4
Oklahoma 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Levocetirizine Dihydrochloride

Clinical Trial Phase

Clinical Trial Phase for Levocetirizine Dihydrochloride
Clinical Trial Phase Trials
Phase 4 25
Phase 3 17
Phase 2 4
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Levocetirizine Dihydrochloride
Clinical Trial Phase Trials
Completed 53
Terminated 2
Unknown status 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Levocetirizine Dihydrochloride

Sponsor Name

Sponsor Name for Levocetirizine Dihydrochloride
Sponsor Trials
UCB Pharma 30
GlaxoSmithKline 5
Hanmi Pharmaceutical Company Limited 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Levocetirizine Dihydrochloride
Sponsor Trials
Industry 52
Other 16
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Express Scripts
Cerilliant
Fish and Richardson
US Department of Justice
Queensland Health
Daiichi Sankyo
Cipla
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.